Blog
Read the latest industry insights
Featured blogs
A More Practical Approach to HIPAA Expert Determination
Most Expert Determinations are not shaped by statistical analysis alone. They are also shaped by factors beyond the dataset, including how the data will be used, who can…
Read MoreA More Practical Approach to HIPAA Expert Determination
Protecting Patient Privacy Through Responsible Access to Health Information
Healthcare is undergoing a historic digital transformation. Advances in interoperability, data sharing, and health information exchange have the potential to improve care coordination, reduce administrative burden, and empower…
Read MoreProtecting Patient Privacy Through Responsible Access to Health Information
Assessing Re-identification Risk from Veteran Status in HIPAA Expert Determination
Introduction Veterans in the United States shouldn’t have to worry about the privacy of their health data. Between data breaches of the Veterans Health Administration and CPAP Medical…
Read MoreAssessing Re-identification Risk from Veteran Status in HIPAA Expert Determination
Datavant Life Sciences’ AI Platform: Scientific Rigor at Scale
Life Sciences organizations face growing pressure to generate real-world evidence (RWE) faster and at greater scale-for internal decision-making, publication, and external stakeholders, including regulators and payers.Speed is now…
Read MoreDatavant Life Sciences’ AI Platform: Scientific Rigor at Scale
Patient Access in the Age of Interoperability: Preserving Trust as Access Scales
Healthcare has made real progress on digital access. Portals are common. APIs are expanding. Federal policy continues to reinforce what should be obvious: patients have a right to…
Read MorePatient Access in the Age of Interoperability: Preserving Trust as Access Scales
3 Data Trends Shaping Clinical Research and RWE in 2026 and beyond
Life Sciences is at an inflection point. Real-world data (RWD) and AI have progressed from pilot programs and proof-of-concept experimentation to core components of clinical development and evidence…
Read More3 Data Trends Shaping Clinical Research and RWE in 2026 and beyond
From Optional to Foundational: RWE in the Era of One Trial
I. The Persistent Execution Gap in RWE Generation in Clinical Development We have previously articulated the case for systematic, integrated RWE generation beginning early in drug development -…
Read MoreFrom Optional to Foundational: RWE in the Era of One Trial
How AI Is Powering Smarter, Privacy-Preserving Data Discovery for Life Sciences
Life sciences organizations have long struggled with fragmented, time-intensive processes for discovering, assessing, and purchasing real-world data (RWD). These bottlenecks delay evidence generation, slow clinical and commercial decision-making,…
Read More

